A detailed history of Hya Advisors, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Hya Advisors, Inc holds 2,005 shares of ABT stock, worth $235,306. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,005
Previous 1,999 0.3%
Holding current value
$235,306
Previous $237,000 8.02%
% of portfolio
0.09%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

BUY
$102.07 - $123.37 $612 - $740
6 Added 0.3%
2,005 $218,000
Q1 2022

Apr 12, 2022

SELL
$114.02 - $139.04 $19,497 - $23,775
-171 Reduced 7.88%
1,999 $237,000
Q4 2021

Jan 26, 2022

BUY
$115.53 - $141.46 $346 - $424
3 Added 0.14%
2,170 $305,000
Q3 2021

Oct 12, 2021

BUY
$116.66 - $129.06 $583 - $645
5 Added 0.23%
2,167 $253,000
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $528 - $622
5 Added 0.23%
2,162 $251,000
Q1 2021

Apr 16, 2021

BUY
$108.84 - $128.23 $234,767 - $276,592
2,157 New
2,157 $258,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Hya Advisors, Inc Portfolio

Follow Hya Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hya Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hya Advisors, Inc with notifications on news.